-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Kura Oncology, Maintains $40 Price Target

Benzinga·01/13/2026 12:29:32
Listen to the news
HC Wainwright & Co. analyst Joseph Pantginis reiterates Kura Oncology (NASDAQ:KURA) with a Buy and maintains $40 price target.